SCHEMBL4905093

SCHEMBL4905093

O=[N+]([O-])c1cccc2nccc(Cl)c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
TDP1 Q9NUW8 5/20 0.58
KDM4E B2RXH2 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
POLB P06746 1/20 0.54
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
EGFR P00533 2/20 0.45
PDE10A Q9Y233 1/20 0.44
TXNRD1 Q16881 1/20 0.42
TXNRD3 Q86VQ6 1/20 0.42
TXNRD2 Q9NNW7 1/20 0.42
MAPT P10636 3/20 0.42
PKM P14618 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSP90AA1 P07900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27789837 0.80 POLB (0.54) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL31067270 0.80 POLB (0.54) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL3274442 0.80 POLB (0.54) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL31067279 0.77 POLB (0.50) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL11246685 0.77 EGFR (0.55) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL30517039 0.76 KDM4E (0.50) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL8545932 0.76 KDM4E (0.50) ALDH1A1TDP1KDM4EMEN1KMT2A
SCHEMBL6465602 0.76 PARP1 (0.50) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL29404834 0.76 PARP1 (0.50) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL5674149 0.74 POLB (0.47) ALDH1A1TDP1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045538-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2008-02-21 US disclosed
US-6992089-B2 Nitro and amino substituted topoisomerase agents RUTGERS, THE UNIVERSITY OF NEW JERSEY (US) 2006-01-31 US disclosed
US-20040102443-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2004-05-27 US disclosed
WO-2004014906-A2 NITRO AND AMINO SUBSTITUTED DIBENZONAPHTHYRIDINES AS TOPOISOMERASE AGENTS RUTGERS, THE STATE UNIVERSITY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045538-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B ALDH1A1 2380/4885TDP1 6/4885KDM4E 1064/4885
US-20040102443-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B ALDH1A1 1476/4885TDP1 4/4885KDM4E 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.